| | |
 |  | |
 | ||
 | |     Subscribe to our Email List  | |  The information set out on these pages is collated in accordance with AIM Rule 26 and was last updated on 5 January 2012. Verona Pharma is incorporated in the United Kingdom and has its principal office in central London. The Company's registered number is 5375156 and its registered office is at One America Square, Crosswall, London EC3N 2SG. The Company's issued share capital consists of 285,845,075 ordinary shares with a nominal value of 0.1p each ("Ordinary Shares"), each share having equal voting rights. The Company does not hold any Ordinary shares in treasury and therefore the number of Ordinary Shares with voting rights is 285,845,075. In accordance with AIM Rule 26, in so far as the Company is aware, the percentage of the Company's issued share capital that is not in public hands is 10.9%. The percentage of the Company's issued share capital held by the Directors and management is 11.7%. The Company is not listed on any other exchanges or trading platforms. There are no restrictions on the transfer of the Company's securities. Information about the Directors can be found here Information about Corporate Governance can be found here Information about the Company can be found here Information about the Significant Shareholders can be found here Information about News & Events can be found here Information about Key Advisers can be found here | | |
| ||
| | |
| ||
| Home Company Information Products AIM Rule 26 News Releases Contact For Staff | |
| ©2006 Verona Pharma Plc All Rights Reserved. | Disclaimer | |